Record-Breaking Price Movement
On 2 July 2026, Zydus Wellness Ltd’s share price surged to an intraday high of Rs.582.40, representing a 2.49% increase on the day. The stock closed near this peak at Rs.583.00, registering a daily gain of 2.60%, significantly outperforming the Sensex, which rose by just 0.39% on the same day. This new 52-week high surpasses the previous price levels, underscoring the stock’s bullish momentum.
The stock’s performance also outpaced its FMCG sector peers, outperforming the sector by 1.64% on the day. Zydus Wellness is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust technical strength and investor confidence.
Strong Relative Performance Across Timeframes
Examining the stock’s performance over various periods highlights its consistent upward trajectory. Over the past week, Zydus Wellness gained 12.95%, compared to a marginal 0.16% rise in the Sensex. The one-month return stands at 17.06%, vastly outperforming the Sensex’s 3.45% gain. Over three months, the stock surged 31.31%, while the Sensex managed only 5.32%.
On a longer-term basis, the stock’s one-year performance is particularly notable, with a 46.19% increase compared to the Sensex’s decline of 7.42%. Year-to-date, Zydus Wellness has risen 27.72%, while the broader market index has fallen 9.38%. Over three years, the stock nearly doubled, appreciating 96.34%, far exceeding the Sensex’s 19.32% gain. Even over a decade, the stock has delivered a remarkable 269.71% return, outperforming the Sensex’s 184.48% growth.
Valuation Metrics Reflect Premium Positioning
As of 2 July 2026, Zydus Wellness Ltd’s valuation multiples indicate a premium market positioning. The price-to-earnings (P/E) ratio on a trailing twelve months (TTM) basis stands at 76x, reflecting investor willingness to pay a higher multiple for the company’s earnings. The price-to-book value (P/BV) ratio is 3.11x, while the enterprise value to EBITDA (EV/EBITDA) ratio is 41.64x, and EV to EBIT ratio is 58.46x. The EV to sales multiple is 5.36x, and EV to capital employed is 2.38x.
Dividend metrics show a modest yield of 0.21%, with the latest dividend declared at Rs.1.2 per share and a payout ratio of 11.00%. The ex-dividend date is scheduled for 11 July 2025.
Technical Analysis Confirms Bullish Trend
The overall technical trend for Zydus Wellness Ltd is bullish, a status that has been in place since 4 May 2026 when the stock crossed ₹509.65. Weekly and monthly technical indicators such as MACD and KST are bullish, while the Relative Strength Index (RSI) shows a bearish signal, indicating some caution in momentum. Bollinger Bands suggest a bullish to mildly bullish stance, and moving averages reinforce the positive trend.
Key support levels include the 52-week low of ₹357.55, while resistance levels previously observed at the 20-day moving average (₹520.07), 100-day moving average (₹466.19), and 200-day moving average (₹460.79) have been decisively surpassed. The new 52-week high at ₹582.40 now represents a far resistance level.
Delivery Volumes Indicate Strong Market Participation
Recent delivery volumes have shown a positive trend, with a 1-month delivery volume increase of 37.79% and a 1-day delivery volume surge of 56.28% compared to the 5-day average. On 1 July 2026, delivery volume was recorded at 2.47 lakh shares, constituting 30.50% of total volume, well above the trailing one-month average of 2.43 lakh shares (19.06% of total volume). This suggests heightened trading activity and investor engagement around the stock’s recent price movements.
Quality Assessment Highlights Average Financial Strength
Zydus Wellness Ltd is classified as an average quality company based on its long-term financial performance. The management risk is assessed as average, with below-average growth metrics. The company’s capital structure is rated excellent, reflecting prudent financial management.
Key quality factors include a five-year sales compound annual growth rate (CAGR) of 16.24%, while EBIT growth over the same period is modest at 2.61%. The average EBIT to interest coverage ratio stands at 15.36x, indicating adequate ability to service interest expenses. Debt metrics show moderate leverage, with an average debt to EBITDA ratio of 2.15 and net debt to equity ratio of 0.53.
Other indicators include an average sales to capital employed ratio of 0.41x and a tax ratio of 14.45%. Institutional holdings are relatively high at 22.05%, and there is no promoter share pledging. However, average return on capital employed (ROCE) and return on equity (ROE) are weak at 5.62% and 5.60%, respectively.
Recent Financial Trends Show Mixed Signals
In the short term, the company’s financial trend as of March 2026 is flat. Quarterly profit after tax (PAT) reached ₹162.00 crores, growing by 161.4% compared to the previous four-quarter average. Net sales for the quarter were the highest recorded at ₹1,484.70 crores, with profit before depreciation, interest, and tax (PBDIT) at ₹270.10 crores and profit before tax less other income (PBT less OI) at ₹176.10 crores, both at record levels.
Conversely, interest expenses over the latest six months increased sharply by 339.01% to ₹79.90 crores. PAT for the same period declined by 27.82% to ₹128.70 crores, and the debt-to-equity ratio rose to its highest at 0.55 times, indicating increased financial costs and leverage in the short term.
Market Capitalisation and Rating Overview
Zydus Wellness Ltd is classified as a small-cap company within the FMCG sector. The company’s Mojo Score stands at 60.0, with a current Mojo Grade of Hold, upgraded from Sell on 16 March 2026. This rating reflects a balanced view of the company’s recent performance and valuation metrics.
Summary
Zydus Wellness Ltd’s stock reaching an all-time high of Rs.582.40 on 2 July 2026 marks a significant achievement, underscoring the company’s sustained growth and strong market positioning. The stock’s consistent outperformance relative to the Sensex and its sector peers across multiple timeframes highlights its resilience and appeal. While valuation multiples indicate a premium, the technical and delivery volume trends confirm a bullish market sentiment. The company’s average quality rating and mixed short-term financial trends provide a comprehensive view of its current standing in the FMCG landscape.
